Regeneron
Proxy Statement
Project details
“Demonstrating the power of science” – Regeneron discovered, developed, and manufactured its novel REGEN-COVTM antibody cocktail treatment for COVID-19 in record time. With simplified information design and clear language, the 2021 Proxy invites readers to meet the board and learn how executive strategy drives the discovery of life-transforming medicines, which, in turn, creates long-term, sustainable shareholder value.